Cefiderocol-compared to colistin-based regimens for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii
M Falcone, G Tiseo, A Leonildi… - Antimicrobial Agents …, 2022 - Am Soc Microbiol
Cefiderocol may represent a therapeutic option for carbapenem-resistant Acinetobacter
baumannii (CRAB) infections, but clinical data are limited. This is an observational …
baumannii (CRAB) infections, but clinical data are limited. This is an observational …
Cefiderocol-Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
M Falcone, G Tiseo, A Leonildi, L Della Sala… - Antimicrobial Agents …, 2022 - cir.nii.ac.jp
抄録< jats: p> Cefiderocol may represent a therapeutic option for carbapenem-resistant<
jats: named-content content-type=" genus-species"> Acinetobacter baumannii</jats: named …
jats: named-content content-type=" genus-species"> Acinetobacter baumannii</jats: named …
Cefiderocol-Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii.
M Falcone, G Tiseo, A Leonildi… - Antimicrobial Agents …, 2022 - europepmc.org
Cefiderocol may represent a therapeutic option for carbapenem-resistant Acinetobacter
baumannii (CRAB) infections, but clinical data are limited. This is an observational …
baumannii (CRAB) infections, but clinical data are limited. This is an observational …
Cefiderocol-Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
M Falcone, G Tiseo, A Leonildi… - ANTIMICROBIAL …, 2022 - art.torvergata.it
Cefiderocol may represent a therapeutic option for carbapenem-resistant Acinetobacter
baumannii (CRAB) infections, but clinical data are limited. This is an observational …
baumannii (CRAB) infections, but clinical data are limited. This is an observational …
Cefiderocol-Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
M Falcone, G Tiseo, A Leonildi… - Antimicrobial …, 2022 - pubmed.ncbi.nlm.nih.gov
Cefiderocol may represent a therapeutic option for carbapenem-resistant Acinetobacter
baumannii (CRAB) infections, but clinical data are limited. This is an observational …
baumannii (CRAB) infections, but clinical data are limited. This is an observational …
Cefiderocol-Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
M Falcone, G Tiseo, A Leonildi, L Della Sala… - ANTIMICROBIAL …, 2022 - arpi.unipi.it
: Cefiderocol may represent a therapeutic option for carbapenem-resistant Acinetobacter
baumannii (CRAB) infections, but clinical data are limited. This is an observational …
baumannii (CRAB) infections, but clinical data are limited. This is an observational …
[HTML][HTML] Cefiderocol-Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
M Falcone, G Tiseo, A Leonildi… - Antimicrobial Agents …, 2022 - ncbi.nlm.nih.gov
Cefiderocol may represent a therapeutic option for carbapenem-resistant Acinetobacter
baumannii (CRAB) infections, but clinical data are limited. This is an observational …
baumannii (CRAB) infections, but clinical data are limited. This is an observational …
[PDF][PDF] Cefiderocol-Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
M Falcone, G Tiseo, A Leonildi, L Della Sala… - 2022 - core.ac.uk
Cefiderocol may represent a therapeutic option for carbapenem-resistant Acinetobacter
baumannii (CRAB) infections, but clinical data are limited. This is an observational …
baumannii (CRAB) infections, but clinical data are limited. This is an observational …
Cefiderocol-Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii.
M Falcone, G Tiseo, A Leonildi… - Antimicrobial Agents …, 2022 - europepmc.org
Cefiderocol may represent a therapeutic option for carbapenem-resistant Acinetobacter
baumannii (CRAB) infections, but clinical data are limited. This is an observational …
baumannii (CRAB) infections, but clinical data are limited. This is an observational …
[PDF][PDF] Cefiderocol-Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
M Falcone, G Tiseo, A Leonildi, L Della Sala… - 2022 - art.torvergata.it
Cefiderocol may represent a therapeutic option for carbapenem-resistant Acinetobacter
baumannii (CRAB) infections, but clinical data are limited. This is an observational …
baumannii (CRAB) infections, but clinical data are limited. This is an observational …